Name: Pfizer seeks COVID-19 vaccine authorization for 12-15 year olds in US
Brand: inquirer.net
SKU: inquirer-net-43
Availability: OnlineOnly

critic

Pfizer seeks COVID-19 vaccine authorization for 12-15 year olds in US

preview

Sectionsnewsinfo // 01:48 AM April 10, 2021 (Photo by JUSTIN TALLIS / AFP)WASHINGTON – Pfizer-BioNTech asked for authorization Friday to use their Covid-19 vaccine on 12-15 year olds in the United States.The companies said in a statement that they plan to make similar requests of other regulatory authorities worldwide in coming days.Their request to the Food and Drug Administration in the US comes after Phase 3 clinical trials of the Pfizer vaccine in 12-15 year olds were 100 pc effective in warding off the disease, according to the companies.In late March they published the results of trials carried out with 2,260 adolescents in the US who the companies said showed “robust anti-body responses.”FEATURED STORIESNEWSINFONEWSINFONEWSINFOThe vaccine was “well tolerated with side effects generally consistent with those observed in participants 16 to 25 years of age,” the companies said Friday.For now the vaccine has emergency authorization for use in people 16 and older.Children are less likely to develop severe Covid so vaccinating them has been less of a priority than getting older people inoculated.The BioNTech/Pfizer shot is based on novel mRNA technology and was the first Covid-19 vaccine to be approved in the West late last year.gsgSubscribe to to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.For feedback, complaints, or inquiries,EDITORS' PICKMOST READglobalnationnewsinfotechnologynewsinfoentertainmenttechnologyglobalnationentertainmentnewsinfoglobalnationnewsinfosportsDisclaimer: Comments do not represent the views of INQUIRER.net. We reserve the right to exclude comments which are inconsistent with our editorial standards.© Copyright 1997-2021 INQUIRER.net | All Rights ReservedWe use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more,I Agree

Sectionsnewsinfo // 01:48 AM April 10, 2021 (Photo by JUSTIN TALLIS / AFP)WASHINGTON – Pfizer-BioNTech asked for authorization Friday to use their Covid-19 vaccine on 12-15 year olds in the United States.The companies said in a statement that they plan to make similar requests of other regulatory authorities worldwide in coming days.Their request to the Food and Drug Administration in the US comes after Phase 3 clinical trials of the Pfizer vaccine in 12-15 year olds were 100 pc effective in warding off the disease, according to the companies.In late March they published the results of...

public

Las noticias y las historias del mundo con el aporte de los periodistas de la AFP en 150 países. También en Facebook: http://u.afp.com/AFPespanol

Agence France-Presse

inquirer.net

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

Pfizer seeks COVID-19 vaccine authorization for 12-15 year olds in US

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS

Pfizer seeks COVID-19 vaccine authorization for 12-15 year olds in US

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS

Subscribe to the Credder Daily

Five Credder articles in your inbox, daily